Company Filing History:
2 out of 382 
1 out of 212 Years Active: 1979-1992
Title: Shingo Uchida: Innovator in Pharmaceutical and Antibiotic Research
Introduction
Shingo Uchida is a notable inventor based in Yokohama, Japan. He has made significant contributions to the fields of pharmaceuticals and antibiotics, holding a total of 3 patents. His work focuses on developing therapeutic agents that address critical health issues.
Latest Patents
Uchida's latest patents include a pharmaceutical composition and method for angiogenesis inhibition. This invention involves Actinonin or a salt thereof, which is active as an inhibitor of angiogenesis in mammals. It is particularly useful as a therapeutic agent for inhibiting angiogenesis in mammals suffering from diabetic retinopathy or inflammatory responses accompanied by angiogenesis. Another significant patent is for the antibiotic SF-1942 substance and the process for its production. This antibiotic is produced by cultivating an SF-1942 substance-producing strain of the genus Streptomyces in a nutrient medium under aerobic conditions. The SF-1942 substance has shown effectiveness as an antimicrobial agent and an antitumor agent against Sarcoma 180 tumor cells in mice.
Career Highlights
Throughout his career, Uchida has worked with prominent companies such as Meiji Seika Kaisha, Ltd. and Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai. His experience in these organizations has contributed to his expertise in pharmaceutical and antibiotic research.
Collaborations
Uchida has collaborated with notable coworkers, including Takashi Shomura and Hiroshi Watanabe. These partnerships have likely enhanced his research and development efforts in the field.
Conclusion
Shingo Uchida's innovative work in pharmaceuticals and antibiotics demonstrates his commitment to advancing medical science. His patents reflect significant advancements that could benefit various health conditions.